Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol

被引:7
|
作者
Juren, Andrew J. [1 ]
Sarwal, Gautamn [1 ,2 ]
Al-Sarraf, Ahmad [1 ,2 ]
Vrablik, Michal [4 ]
Chan, Darren [5 ]
Humphries, Karin H. [6 ]
Frohlich, Jiri J. [1 ,3 ]
机构
[1] St Pauls Hosp, Hlth Heart Program Prevent Clin, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Vancouver, BC V6Z 1Y6, Canada
[2] Univ British Columbia, MD Undergrad Program, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada
[4] Charles Univ Prague, Fac Med 1, Dept Internal Med 3, Prague, Czech Republic
[5] St Georges Univ London, London, England
[6] UBC Heart & Stroke Fdn, Providence Hlth Care Res Inst, Vancouver, BC, Canada
关键词
Cholesterol; Coronary artery disease; Dyslipidemia; Framingham Risk Score; Type 2 diabetes mellitus; CARDIOVASCULAR-DISEASE; HDL; RISK; DYSLIPIDEMIA; GUIDELINES; REDUCTION;
D O I
10.1016/j.jacl.2013.02.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Diabetes mellitus and low levels of high-density lipoprotein cholesterol (HDL-C) are among several known risk factors for coronary artery disease. Recent research has shown potential mechanistic links between these two diseases. OBJECTIVES: The aim of our study was to characterize, by examining particular coronary artery disease risk factors, patients with extremely high and low levels of HDL-C who were referred to a prevention clinic. METHODS: We compared the phenotypes of 113 patients with HDL-C levels greater than the 90th percentile with 212 patients with levels less than the 10th percentile by using a retrospective chart review. RESULTS: The cohort with high HDL-C had a remarkable difference in the incidence of type 2 diabetes (1.8% vs 21.7%). The high HDL-C cohort also had a greater age (52.1 years vs 46.7 years), more light or moderate alcohol consumption (70.8% vs 49.4%), more healthy diet (30.1% vs 22.4%), more light or moderate exercise (90.8% vs 52.2%), and a lower body mass index (25.2 kg/m(2) vs 28.1 kg/m(2)). CONCLUSIONS: Compared with the low HDL-C group-and also the general population-the high HDL-C cohort had a remarkably low prevalence of diabetes mellitus. (C) 2013 National Lipid Association. All rights reserved.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [1] Rosiglitazone increases high-density lipoprotein cholesterol levels in patients with type 2 diabetes
    Schaefer, E
    Gould, E
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 316A - 316A
  • [2] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN DIABETES-MELLITUS
    MATEOS, JMG
    DIAZ, JP
    [J]. REVISTA CLINICA ESPANOLA, 1983, 170 (3-4): : 107 - 113
  • [3] Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus
    Maahs, DM
    Maniatis, AK
    Nadeau, K
    Wadwa, RP
    McFann, K
    Klingensmith, GJ
    [J]. JOURNAL OF PEDIATRICS, 2005, 147 (04): : 544 - 546
  • [4] Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus
    Tan, Hong Chang
    Tai, E. Shyong
    Sviridov, Dmitri
    Nestel, Paul J.
    Ng, Cindy
    Chan, Edmund
    Teo, Yvonne
    Wai, Daniel Chun Hang
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (06) : 467 - 473
  • [5] ALEGLITAZAR LOWERS THE TRIGLYCERIDE/HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Nicholls, Stephen J.
    Henry, Robert
    Reigner, Sylvie Meyer
    Rabbia, Michael
    Herz, Matthias
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1661 - E1661
  • [6] Simvastatin significantly raises high-density lipoprotein cholesterol in patients with type 2 diabetic dyslipidaemia and low high-density lipoprotein cholesterol
    Miller, M
    Borisute, H
    Yuan, Z
    Battisti, W
    Palmisano, J
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 463 - 463
  • [7] Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus
    Araki, Takahiro
    Emoto, Masanori
    Konishi, Toshiaki
    Ikuno, Yoshiko
    Lee, Eiko
    Teramura, Megumi
    Motoyama, Koka
    Yokoyama, Hisayo
    Mori, Katsuhito
    Koyama, Hidenori
    Shoji, Tetsuo
    Nishizawa, Yoshiki
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (02): : 143 - 148
  • [8] Glycation of high-density lipoprotein in type 2 diabetes mellitus
    SUN Jia-teng
    SHEN Ying
    Lü An-kang
    LU Lin
    SHEN Wei-feng
    [J]. 中华医学杂志(英文版), 2013, 126 (21) : 4162 - 4165
  • [9] Glycation of high-density lipoprotein in type 2 diabetes mellitus
    Sun Jia-teng
    Shen Ying
    Lu An-kang
    Lu Lin
    Shen Wei-feng
    [J]. CHINESE MEDICAL JOURNAL, 2013, 126 (21) : 4162 - 4165
  • [10] Inverse Association Between HDL (High-Density Lipoprotein) Cholesterol and Stroke Risk Among Patients With Type 2 Diabetes Mellitus
    Shen, Yun
    Shi, Lizheng
    Nauman, Elizabeth
    Katzmarzyk, Peter T.
    Price-Haywood, Eboni G.
    Bazzano, Alessandra N.
    Nigam, Somesh
    Hu, Gang
    [J]. STROKE, 2019, 50 (02) : 291 - 297